Literature DB >> 21039823

Development of MRI T2 hyperintensities and cognitive functioning in patients with neurofibromatosis type 1.

Reinhold Feldmann1, Gerhard Schuierer, Astrid Wessel, Nina Neveling, Josef Weglage.   

Abstract

BACKGROUND: In patients with neurofibromatosis type 1 (NF1), cognitive deficits are frequent manifestations. They are associated with focal areas of high signal intensity (T2H) on T₂-weighted MRI of the brain. Changes in T2H may affect cognitive development. Our study was to analyse the relations between the long-term development of T2H development and the cognitive abilities in patients with NF1.
METHOD: In a controlled prospective study, we investigated 67 patients with NF1 for their IQ with the patients having T2H (MRI) examination. Assessments and MRI were repeated at a 3- year follow-up.
RESULTS: Patients without T2H performed at the average IQ level. Patients with stable T2H performed below average level but within normal limits of IQ. Patients with T2H that decreased over study period performed well below normal limits at first examination but within limits at follow-up. Stable T2H were found primarily in the cerebellum and the capsula interna. T2H that decreased were found primarily in the thalamus and the basal ganglia.
CONCLUSIONS: T2H in the cerebellum and the capsula interna are more permanent but exert a minor left shift in IQ. T2H in the thalamus or the basal ganglia are related to severely reduced performance. Decreasing they give way for performance improvement. There may be a different pathology in T2H related to the intracranial regions the T2H affect in patients with NF1.
© 2010 The Author(s)/Journal Compilation © 2010 Foundation Acta Paediatrica.

Entities:  

Mesh:

Year:  2010        PMID: 21039823     DOI: 10.1111/j.1651-2227.2010.01923.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  8 in total

1.  Reduced cerebral arterial spin-labeled perfusion in children with neurofibromatosis type 1.

Authors:  K W Yeom; R M Lober; P D Barnes; C J Campen
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-13       Impact factor: 3.825

2.  Focal Areas of High Signal Intensity in Children with Neurofibromatosis Type 1: Expected Evolution on MRI.

Authors:  S Calvez; R Levy; R Calvez; C-J Roux; D Grévent; Y Purcell; K Beccaria; T Blauwblomme; J Grill; C Dufour; F Bourdeaut; F Doz; M P Robert; N Boddaert; V Dangouloff-Ros
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-13       Impact factor: 3.825

3.  Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.

Authors:  Edward Kim; Yuan Wang; Sun-Jung Kim; Miriam Bornhorst; Emmanuelle S Jecrois; Todd E Anthony; Chenran Wang; Yi E Li; Jun-Lin Guan; Geoffrey G Murphy; Yuan Zhu
Journal:  Elife       Date:  2014-12-23       Impact factor: 8.140

Review 4.  Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.

Authors:  Martha Milade Torres Nupan; Alberto Velez Van Meerbeke; Claudia Alejandra López Cabra; Paula Marcela Herrera Gomez
Journal:  Front Pediatr       Date:  2017-10-30       Impact factor: 3.418

5.  Sporadic and Familial Variants in NF1: An Explanation of the Wide Variability in Neurocognitive Phenotype?

Authors:  Maëlle Biotteau; Sébastien Déjean; Sandrine Lelong; Stéphanie Iannuzzi; Nathalie Faure-Marie; Pierre Castelnau; François Rivier; Valérie Lauwers-Cancès; Eloïse Baudou; Yves Chaix
Journal:  Front Neurol       Date:  2020-05-05       Impact factor: 4.003

6.  Increased prevalence of brain tumors classified as T2 hyperintensities in neurofibromatosis 1.

Authors:  Jennifer L Griffith; Stephanie M Morris; Jasia Mahdi; Manu S Goyal; Tamara Hershey; David H Gutmann
Journal:  Neurol Clin Pract       Date:  2018-08

7.  Characterizing the microstructural basis of "unidentified bright objects" in neurofibromatosis type 1: A combined in vivo multicomponent T2 relaxation and multi-shell diffusion MRI analysis.

Authors:  Thibo Billiet; Burkhard Mädler; Felice D'Arco; Ronald Peeters; Sabine Deprez; Ellen Plasschaert; Alexander Leemans; Hui Zhang; Bea Van den Bergh; Mathieu Vandenbulcke; Eric Legius; Stefan Sunaert; Louise Emsell
Journal:  Neuroimage Clin       Date:  2014-04-13       Impact factor: 4.881

8.  Brain Tumors in NF1 Children: Influence on Neurocognitive and Behavioral Outcome.

Authors:  Matilde Taddei; Alessandra Erbetta; Silvia Esposito; Veronica Saletti; Sara Bulgheroni; Daria Riva
Journal:  Cancers (Basel)       Date:  2019-11-11       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.